Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.

Gordiienko I, Shlapatska L, Kholodniuk VM, Kovalevska L, Ivanivskaya TS, Sidorenko SP.

Exp Oncol. 2017 Dec;39(4):291-298.

PMID:
29284783
2.

The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.

Gordiienko I, Shlapatska L, Kholodniuk V, Sklyarenko L, Gluzman DF, Clark EA, Sidorenko SP.

PLoS One. 2017 Oct 5;12(10):e0185940. doi: 10.1371/journal.pone.0185940. eCollection 2017.

3.

Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.

Schwartz AM, Putlyaeva LV, Covich M, Klepikova AV, Akulich KA, Vorontsov IE, Korneev KV, Dmitriev SE, Polanovsky OL, Sidorenko SP, Kulakovskiy IV, Kuprash DV.

Biochim Biophys Acta. 2016 Oct;1859(10):1259-68. doi: 10.1016/j.bbagrm.2016.07.004. Epub 2016 Jul 14.

PMID:
27424222
4.

Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.

Gordiienko IM, Shlapatska LM, Kovalevska LM, Sidorenko SP.

Exp Oncol. 2016 Jun;38(2):101-7.

PMID:
27356578
5.

Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response.

Romanets-Korbut O, Kovalevska LM, Seya T, Sidorenko SP, Horvat B.

Cell Mol Immunol. 2016 Nov;13(6):828-838. doi: 10.1038/cmi.2015.55. Epub 2015 Jun 15.

6.

Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.

Romanets-Korbut O, Najakshin AM, Yurchenko M, Malysheva TA, Kovalevska L, Shlapatska LM, Zozulya YA, Taranin AV, Horvat B, Sidorenko SP.

PLoS One. 2015 Feb 24;10(2):e0118302. doi: 10.1371/journal.pone.0118302. eCollection 2015.

8.
9.

The multilevel regulation of CD95 signaling outcome.

Yurchenko M, Shlapatska LM, Sidorenko SP.

Exp Oncol. 2012 Oct;34(3):153-9. Review.

PMID:
23069999
10.

Differential expression of PKD1 and PKD2 in gastric cancer and analysis of PKD1 and PKD2 function in the model system.

Shabelnik MY, Kovalevska LM, Yurchenko MY, Shlapatska LM, Rzepetsky Y, Sidorenko SP.

Exp Oncol. 2011 Dec;33(4):206-11.

PMID:
22217708
11.

CD150-mediated Akt signalling pathway in normal and malignant B cells.

Yurchenko M, Shlapatska LM, Romanets OL, Ganshevskiy D, Kashuba E, Zamoshnikova A, Ushenin YV, Snopok BA, Sidorenko SP.

Exp Oncol. 2011 Mar;33(1):9-18.

PMID:
21423089
12.

Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.

Yurchenko M, Sidorenko SP.

Exp Oncol. 2010 Dec;32(4):214-23. Review.

PMID:
21270747
13.

FCRL6 receptor: expression and associated proteins.

Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA, Chikaev NA, Reshetnikova ES, Kashirina NM, Peclo MM, Rutkevich PN, Shevelev AY, Yanushevskaya EV, Baranov KO, Mamonkin M, Vlasik TN, Sidorenko SP, Taranin AV, Mechetina LV.

Immunol Lett. 2011 Jan 30;134(2):174-82. doi: 10.1016/j.imlet.2010.09.023. Epub 2010 Oct 7.

PMID:
20933011
14.

CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells.

Yurchenko MY, Kovalevska LM, Shlapatska LM, Berdova GG, Clark EA, Sidorenko SP.

Immunol Cell Biol. 2010 Jul;88(5):565-74. doi: 10.1038/icb.2010.14. Epub 2010 Mar 16.

PMID:
20231852
15.

Helicobacter pylori infection of gastric cancer cells elevates the level of expression and activation of protein kinase D2.

Shabelnik MY, Kostyuk OV, Merentsev SV, Tarasova TO, Sidorenko SP.

Exp Oncol. 2009 Sep;31(3):134-9.

PMID:
19783969
16.

Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas.

Kovalevska LM, Yurchenko OV, Shlapatska LM, Berdova GG, Mikhalap SV, Van Lint J, Sidorenko SP.

Exp Oncol. 2006 Sep;28(3):225-30.

PMID:
17080017
17.

The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.

Yurchenko MY, Kashuba EV, Shlapatska LM, Sivkovich SA, Sidorenko SP.

Exp Oncol. 2005 Mar;27(1):24-30.

PMID:
15812353
18.

Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.

Shlapatska LM, Berdova GG, Kovalevska LM, Kulyk GI, Klein G, Sidorenko SP, Chekhun VF.

Exp Oncol. 2004 Sep;26(3):210-6.

PMID:
15494689
19.

The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.

Mikhalap SV, Shlapatska LM, Yurchenko OV, Yurchenko MY, Berdova GG, Nichols KE, Clark EA, Sidorenko SP.

Blood. 2004 Dec 15;104(13):4063-70. Epub 2004 Aug 17.

20.

The dual-function CD150 receptor subfamily: the viral attraction.

Sidorenko SP, Clark EA.

Nat Immunol. 2003 Jan;4(1):19-24. Review.

PMID:
12496974
21.

Epidermoid carcinoma-derived antimicrobial peptide (ECAP) inhibits phosphorylation by protein kinases in vitro.

Hobta A, Lisovskiy I, Mikhalap S, Kolybo D, Romanyuk S, Soldatkina M, Markeyeva N, Garmanchouk L, Sidorenko SP, Pogrebnoy PV.

Cell Biochem Funct. 2001 Dec;19(4):291-8.

PMID:
11746212
22.

CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.

Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA, Sidorenko SP.

J Immunol. 2001 May 1;166(9):5480-7.

23.

CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.

Mikhalap SV, Shlapatska LM, Berdova AG, Law CL, Clark EA, Sidorenko SP.

J Immunol. 1999 May 15;162(10):5719-27.

24.

Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines.

Rokhlin OW, Hostager BS, Bishop GA, Sidorenko SP, Glover RA, Gudkov AV, Cohen MB.

Cancer Res. 1997 Sep 15;57(18):3941-3.

25.

Fas-mediated apoptosis in human prostatic carcinoma cell lines.

Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB.

Cancer Res. 1997 May 1;57(9):1758-68.

26.

Regulation of signalling through B-lymphocyte antigen receptors by cell-cell interaction molecules.

Law CL, Craxton A, Otipoby KL, Sidorenko SP, Klaus SJ, Clark EC.

Immunol Rev. 1996 Oct;153:123-54. Review. No abstract available.

PMID:
9010722
27.

Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling.

Sidorenko SP, Law CL, Klaus SJ, Chandran KA, Takata M, Kurosaki T, Clark EA.

Immunity. 1996 Oct;5(4):353-63.

28.

Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells.

Polacino PS, Pinchuk LM, Sidorenko SP, Clark EA.

J Med Primatol. 1996 Jun;25(3):201-9.

PMID:
8892041
29.

CD45 ligation induces programmed cell death in T and B lymphocytes.

Klaus SJ, Sidorenko SP, Clark EA.

J Immunol. 1996 Apr 15;156(8):2743-53.

PMID:
8609392
30.
31.

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.

Law CL, Sidorenko SP, Chandran KA, Zhao Z, Shen SH, Fischer EH, Clark EA.

J Exp Med. 1996 Feb 1;183(2):547-60.

32.

Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.

Sidorenko SP, Law CL, Chandran KA, Clark EA.

Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):359-63.

33.

Regulation of lymphocyte activation by the cell-surface molecule CD22.

Law CL, Sidorenko SP, Clark EA.

Immunol Today. 1994 Sep;15(9):442-9. Review.

PMID:
7945784
34.

Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.

Law CL, Sidorenko SP, Chandran KA, Draves KE, Chan AC, Weiss A, Edelhoff S, Disteche CM, Clark EA.

J Biol Chem. 1994 Apr 22;269(16):12310-9.

35.

Accessory molecules that influence signaling through B lymphocyte antigen receptors.

Clark EA, Berberich I, Klaus SJ, Law CL, Sidorenko SP.

Adv Exp Med Biol. 1994;365:35-43. No abstract available.

PMID:
7887311
36.
37.

Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.

Sidorenko SP, Vetrova EP, Yurchenko OV, Berdova AG, Shlapatskaya LN, Gluzman DF.

Neoplasma. 1992;39(1):3-9.

PMID:
1528302
38.

[Immunoenzyme cytochemical methods, monoclonal antibodies and lectins in the diagnosis of tumors of the lymphoid tissue in children].

Gluzman DF, Nadgornaia VA, Skliarenko LM, Abramenko IV, Sidorenko SP, Kaz'mina EV, Livshits EA, Drozdova VD.

Pediatriia. 1991;(11):18-22. Russian.

PMID:
1766734
39.

[Current theories on the origin of Reed-Sternberg cells in lymphogranulomatosis].

Gluzman DF, Sidorenko SP, Poludnenko LIu, Iurchenko OV, Gol'dshmid BIa.

Gematol Transfuziol. 1990 Nov;35(11):24-7. Russian.

PMID:
2283023
40.

[Monoclonal antibodies of the IPO series in studying and diagnosing malignant lymphoproliferative diseases].

Sidorenko SP, Vetrova EP, Iurchenko OV, Shlapatskaia LN, Berdova AG, Elenskaia AM, Bal'shin MD, Gluzman DF.

Gematol Transfuziol. 1990 Apr;35(4):19-22. Russian.

PMID:
2373343
41.

[Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].

Sidorenko SP, Berdova AG, Vetrova EP, Shlapatskaia LN, Iurchenko OV, Evsev'eva AI, Gluzman DF.

Eksp Onkol. 1990;12(3):21-4. Russian.

PMID:
2344819
42.
43.

[Immunocytochemical methods using monoclonal antibodies and lectins in the diagnosis of lymphoblastic leukemia in children].

Gluzman DF, Sidorenko SP, Berdova AG, Skliarenko LM, Nadgornaia VA, Abramenko IV, Poludnenko LIu, Drozdova VD.

Gematol Transfuziol. 1989 Sep;34(9):20-3. Russian.

PMID:
2583456
44.

Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens.

Pinchouk VG, Sidorenko SP, Gluzman DF, Vetrova EP, Berdova AG, Schlapatskaya LN.

Anticancer Res. 1988 Nov-Dec;8(6):1377-80.

PMID:
3265315
45.

[Morphocytochemical and electron microscopic research on murine hybridoma cells producing and not producing monoclonal antibodies].

Sidorenko SP, Gluzman DF, Vetrova EP, Iurchenko OV, Berdova AG.

Tsitologiia. 1988 Jan;30(1):39-43. Russian.

PMID:
3358281
46.
47.

[IPO-10 monoclonal antibodies to the human B-lymphocyte differentiation antigen].

Sidorenko SP, Vetrova EP, Berdova AG, Shlapatskaia LN, Evsev'eva AI.

Eksp Onkol. 1988;10(3):42-4. Russian.

PMID:
2457482
48.

[Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children].

Gluzman DF, Skliarenko LM, Nadgornaia VA, Poludnenko LIu, Sidorenko SP.

Eksp Onkol. 1987;9(3):36-9. Russian.

PMID:
2956083
49.

[Ultrastructural organization of the blood lymphoid cells in hairy cell leukemia].

Iurchenko OV, Sidorenko SP, Pinchuk VG.

Eksp Onkol. 1986;8(3):53-8. Russian.

PMID:
3522197
50.

[Monoclonal antibodies to RPMI-1788 lymphoblastoid line cells].

Pinchuk VG, Sidorenko SP, Vetrova EP, Berdova AG, Shlapatskaia LN.

Eksp Onkol. 1986;8(6):41-6. Russian.

PMID:
3026773

Supplemental Content

Loading ...
Support Center